TABLE 4.
Receptor | Species | Model | Ligand | Effect on expression and/or activity | Reference |
---|---|---|---|---|---|
NR1I3 | Mouse | Isolated capillaries from wild‐type C3H mice | TCPOBOP | ↑ P‐gp, Mrp2, Bcrp | (Wang et al., 2010) |
Isolated capillaries from NR1I3 (−/−) C3H mice | N/E | ||||
Rat | Isolated capillaries from Sprague–Dawley rats | Phenobarbital | ↑ P‐gp, Mrp2, Bcrp | (Wang et al., 2010) | |
Porcine | Primary culture | CITCO | ↑ P‐GP, BCRP | (Lemmen, Tozakidis, Bele, & Galla, 2013) | |
Human | hCMEC/D3 cells | CITCO | ↑ P‐GP | (Chan et al., 2011) | |
NR1I32 | Mouse | Isolated capillaries from wild‐type CB6F1 mice | PCN | ↑ P‐gp | (Bauer et al., 2006) |
Isolated capillaries from hNR1I2 humanised CB6F1 mice |
Rifampicin Hyperforin |
↑ P‐gp | |||
CD‐1 mice | Dexamethasone | ↑ P‐gp (cortical capillaries), N/E Cyp3a11 | (Chan et al., 2013) | ||
Rat | Isolated capillaries from Sprague–Dawley rats |
PCN Dexamethasone |
↑ P‐gp, Gstp | (Bauer et al., 2004; Bauer et al., 2008) | |
Primary culture from Sprague–Dawley rats | Dexamethasone | ↑ P‐GP, Mrp2, Bcrp | (Narang et al., 2008) | ||
Porcine | Primary culture |
Rifampicin Hyperforin |
↑ P‐GP, BCRP | (Ott et al., 2009); (Lemmen, Tozakidis, & Galla, 2013) | |
White large × Landrace hybrid pigs | Rifampicin |
N/E CYP3A22 CYP3A29, CYP3A46 and CYP2B22, P‐GP, MRP1, MRP2 |
(Nannelli et al., 2010) | ||
Human | hCMEC/D3 cells |
Rifampicin SR12813 |
↑ P‐GP | (Chan et al., 2011) | |
Primary culture | ↑ CYP3A4, CYP2C9, CYP2E1 | (Ghosh et al., 2017) |
Note: ↑ denotes increased expression or activity, and ↓ decreased expression or activity.
Abbreviation: N/E, no effect.